RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

BTW--an afterthought. For those who think Cortex should have emphasized Alzheimer's instead, this is a cautionary tale. We understand RD and SA infinitely better than we understand AD. The role of beta-amyloid, or of its varieties, remains debated. Those who claim there is a consensus usually represent one of the Alzheimer 'ideologies', they have a causal axe to grind. Cortex's approach is not integrally linked to a specific theory of what causes AD, what causes cell death within AD, it is not as ideologically-bound: neurotrophic activity might be helpful to cognitive function regardless of the root cause of the disorder. But even so, So the risk of pursuing something that is a dead end, or pursuing something that ends up eclipsed by an alternative, is much higher in Alzheimer's than it is in anything that Cortex has chosen to pursue.

NeuroInvestment